As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Generic Oncology Drugs Market: Regional Analysis; Historical Market and Forecast (2015-2025); Market Dynamics; Value Chain Analysis; Price Analysis; Cost Analysis; Project Economics; Competitive Landscape; Industry Events and Developments

Global Generic Oncology Drugs Market Outlook

The global generic oncology drugs market size was nearly USD 25 billion in 2019. The market is further expected to grow at a CAGR of 9.1% in the forecast period of 2020-2025 to attain USD 42 billion by 2025.

The global generic oncology drugs market is being driven by the growing cancer incidences across the globe coupled with rising demand for such drugs to assist patients undergoing chemotherapy, alleviating after-effects, including pain. 

Region-wise, North America is the leading market for generic oncology drugs accounting for the majority of the global share. The growth of the market in the region can be attributed to the availability of advanced technology and enhanced healthcare infrastructure. On the other hand, the Asia Pacific is expected to be one of the emerging markets owing to the increased government expenditure in the healthcare sector in the region coupled with the presence of increased population.

 

Properties and Applications

Generic oncology drugs refer to the drugs that assist in shrinking, controlling, and eliminating the cancer cells present in the human body. They perform a pivotal role in cancer treatment as some of the anti-cancer drugs are only available in the form of generics. Generic oncology drugs share similar active ingredients as the already marketed brand-name cancer care medicine, and they can be characterised by different colours or flavours in comparison to the original drugs. The performance, intended use, quality, dosage form, and route of administration of these drugs are similar to that of their original counterparts.

The EMR report has analysed the major regional markets in the industry, which are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Market Analysis

The generic oncology drugs market is driven by the growing prevalence of cancer across the globe, coupled with high costs associated with cancer treatment. These drugs are bioequivalent of and are used as an alternative means to brand-name medicines, providing similar pharmacological effects in cancer treatment. A rapid increase in the number of smokers, coupled with a rise in sedentary and unhealthy lifestyles, has increased the incidences of cancer cases around the world. As a result of this, there has been an acceleration in the demand for cost-effective and viable cancer treatments, including generic oncology drugs. Increasing adulteration in food products and the usage of pesticides in fresh fruits and vegetables has injected a lot of chemicals in the human body responsible for such diseases.

Apart from this, rising government expenditure in the emerging nations to promote generic drugs and reduce healthcare expenses is positively influencing the regional market growth. Furthermore, rapid advancements in the healthcare sector and biotechnology and research field have resulted in early and affordable cancer diagnosis, thus increasing the demand for generic oncology drugs at the prevention stage. Thus, rising geriatric population and growing demand for cost-effective treatment procedures, particularly in emerging regions are aiding the industry further.

Factors such as new product launches and benefits offered by generic drugs are boosting the market. In addition, the growing pharmaceutical industry in developing countries is likely to have a positive impact on the growth of the market in the coming years. The ongoing research and development activities are aiding the market growth. Moreover, the leading players in the market are innovating and launching enhanced products, which is expected to have a positive effect on the industry growth over the forecast period.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the global generic oncology drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Mylan N.V.
  • Hikma Pharmaceuticals PLC
  • Stason Pharmaceuticals
  • Mayne Pharma
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

5.1    Overview
5.2    Key Drivers
5.3    Key Developments
5.4    Competitive Structure
5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Generic Oncology Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Generic Oncology Drugs Historical Market (2015-2019) 
    8.3    Global Generic Oncology Drugs Market Forecast (2020-2025)
    8.4    Global Generic Oncology Drugs Market by Region
        8.4.1    Market Share
            8.4.1.1    North America
            8.4.1.2    Europe
            8.4.1.3    Asia Pacific
            8.4.1.4    Latin America
            8.4.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2015-2019)
        9.1.2    Forecast Trend (2020-2025)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2015-2019)
        9.2.2    Forecast Trend (2020-2025)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2015-2019)
        9.3.2    Forecast Trend (2020-2025)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2015-2019)
        9.4.2    Forecast Trend (2020-2025)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2015-2019)
        9.5.2    Forecast Trend (2020-2025)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyers Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Price Analysis
13    Manufacturing Process

    13.1    Overview
    13.2    Detailed Process Flow
    13.3    Operations Involved
14    Cost Analysis
    14.1    Land, Location, and Site Development
    14.2    Construction
    14.3    Plant Machinery
    14.4    Cost of Raw Material
    14.5    Packaging
    14.6    Transportation
    14.7    Utilities
    14.8    Manpower
    14.9    Other Capital Investment
15    Project Economics
    15.1    Capital Cost of the Project
    15.2    Techno-Economic Parameters
    15.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    15.4    Taxation and Depreciation
    15.5    Income Projections
    15.6    Expenditure Projections
    15.7    Financial Analysis
    15.8    Profit Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Company Profiles
        16.3.1    Mylan N.V.
            16.3.1.1    Company Overview
            16.3.1.2    Product Portfolio
            16.3.1.3    Demographic Reach and Achievements
            16.3.1.4    Certifications
        16.3.2    Hikma Pharmaceuticals PLC
            16.3.2.1    Company Overview
            16.3.2.2    Product Portfolio
            16.3.2.3    Demographic Reach and Achievements
            16.3.2.4    Certifications
        16.3.3    Stason Pharmaceuticals
            16.3.3.1    Company Overview
            16.3.3.2    Product Portfolio
            16.3.3.3    Demographic Reach and Achievements
            16.3.3.4    Certifications
        16.3.4    Mayne Pharma
            16.3.4.1    Company Overview
            16.3.4.2    Product Portfolio
            16.3.4.3    Demographic Reach and Achievements
            16.3.4.4    Certifications
    16.3.5    Others
17    Industry Events and Developments

 

List of Figures and Tables

1.    Global Generic Oncology Drugs Market: Key Industry Highlights, 2015 and 2025
2.    Global Generic Oncology Drugs Historical Market: Breakup by Region (USD Billion), 2015-2019
3.    Global Generic Oncology Drugs Market Forecast: Breakup by Region (USD Billion), 2020-2025
4.    North America Generic Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2015-2019
5.    North America Generic Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2020-2025
6.    Europe Generic Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2015-2019
7.    Europe Generic Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2020-2025
8.    Asia Pacific Generic Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2015-2019
9.    Asia Pacific Generic Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2020-2025
10.    Latin America Generic Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2015-2019
11.    Latin America Generic Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2020-2025
12.    Middle East and Africa Generic Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2015-2019
13.    Middle East and Africa Generic Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2020-2025
14.    Global Generic Oncology Drugs Market Structure

Key Questions Answered in the Report

The global generic oncology drugs market reached a value of USD 25 billion in 2019. 

The market is projected to grow at a CAGR of nearly 9.1% in the forecast period of 2020-2025.

The market is estimated to reach a value of about USD 42 billion by 2025.

The major drivers of the industry include rising disposable incomes, increasing population, rising cancer incidences, rising demand for these drugs to assist patients undergoing chemotherapy, alleviating after-effects, including pain, availability of advanced technology and enhanced healthcare infrastructure.

The increased government expenditure in the healthcare industry is expected to be a key trend guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.

The leading players in the market are Mylan N.V., Hikma Pharmaceuticals PLC, Stason Pharmaceuticals, and Mayne Pharma, among others.

Analyst Review

The global generic oncology drugs market attained a value of USD 25 billion in 2019, driven by the growth in the healthcare industry. Aided by the rising demand for these drugs to assist patients undergoing chemotherapy, the industry is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 9.1%. The industry is projected to reach USD 42 billion by 2025. 

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The major regional markets for generic oncology drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include Mylan N.V., Hikma Pharmaceuticals PLC, Stason Pharmaceuticals, and Mayne Pharma, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.  

Purchase Full Report

Mini Report

$ 1099     $999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$ 2999     $1999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$ 3999     $2999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$ 4999     $3999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Anti-Fibrinolytic Drugs Market Report and Forecast 2020-2025


Global Trenbolone Enanthate Market Report and Forecast 2020-2025


Global Alprazolam Powder Market Report and Forecast 2020-2025


Global Legal Marijuana Market Report and Forecast 2020-2025



NEWSLETTER